Labcorp raises FY25 adjusted EPS view to $16.05-$16.50 from $15.70-$16.40

Consensus $16.10. Raises FY25 revenue view to up 7.5%-8.6% from up 6.7%-8%. Raises FY25 free cash flow view to $1.13B-$1.28B from $1.10B-$1.25B. The company said, “Labcorp (LH) is updating 2025 full year guidance to reflect its second quarter performance and full year outlook. The following guidance assumes foreign exchange rates effective as of June 30, 2025, for the remainder of the year. Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions, share repurchases and dividends.”